Hepatitis
HBV vaccine nonresponders should be considered for revaccination after HCV cure
People who were not responsive to hepatitis B vaccination should be considered for revaccination following hepatitis C cure, researchers reported.
Mycophenolate mofetil induces remission in nearly 60% with autoimmune hepatitis
Mycophenolate mofetil was superior to azathioprine in achieving biochemical remission in treatment-naive patients with autoimmune hepatitis who were also treated with prednisolone, according to data presented at EASL Congress.
Hepatitis C cure rates ‘jarringly low’ as many lack access to treatment
An analysis of data from 2013 to 2022 showed that only 34% of people diagnosed with hepatitis C in the United States were cured or cleared of the virus, with many still lacking access to highly effective treatments.
Prophylactic antibiotics do not reduce mortality in severe alcohol-related hepatitis
The use of amoxicillin-clavulanate with prednisolone did not improve 2-month survival compared with prednisolone alone in patients hospitalized with severe alcohol-related hepatitis, according to data in JAMA.
VIDEO: Prevention ‘always better than a cure’ for hepatitis B virus infection
In a Healio video exclusive, Jeff Baxter, president and CEO of VBI Vaccines, discusses the current burden of hepatitis B virus infection and shares updates on prevention and treatment strategies for Hepatitis Awareness Month.
Biden: ‘Every American can do their part’ to eliminate viral hepatitis epidemic in US
May is Hepatitis Awareness Month, an annual campaign to raise awareness for viral hepatitis and its impact in the U.S. — and a month-long opening to address the importance of vaccination and testing for viral hepatitis with your patients.
In proclamation, Biden notes ‘hidden epidemic’ of viral hepatitis
According to HHS, many of the more than 3.2 million people in the United States with hepatitis B or C are not aware of their infection, raising their risk for severe complications or death and risking further spread of the viruses.
Insured women were 15 times more likely to initiate hepatitis treatment
Women who reported having health insurance were significantly more likely to initiate hepatitis C treatment vs. women without health insurance, according to a study published in Clinical Infectious Diseases.
Larsucosteral shows ‘promising efficacy signals’ for alcohol-associated hepatitis
Larsucosteral was well-tolerated and improved short-term biomarkers of liver injury or disease in a subset of patients with moderate to severe alcohol-associated hepatitis, according to research in The American Journal of Gastroenterology.
Dried blood spot test can detect HIV and hepatitis, researchers say
A dried blood spot test can be used to detect HIV, hepatitis B and hepatitis C in a single drop of blood, researchers reported at the European Congress of Clinical Microbiology & Infectious Diseases.